Kimberly-Clark outlines ‘generational’ value opportunity at CAGNY 2026
”We have fundamentally repositioned our business to drive brand love, create lifetime bonds with consumers and deliver value for shareholders,” said CEO Mike Hsu.
Kenvue
Shareholders overwhelmingly approve Kimberly-Clark's acquisition of Kenvue
Transaction expected to close in the second half of 2026.
People Who Made a Difference: Amanda Coussoule, Chief Customer Officer, Kenvue
‘Our job is to be clear in our goals but flexible in how we reach them.’
Kimberly-Clark to acquire Kenvue
Move to create a $32 billion global health and wellness leader
Kenvue taps Jon Halvorson as new chief marketing officer
Company still battling claims from the Trump administration that its painkiller Tylenol is linked to autism.
Kenvue issues official company statement on Tylenol
“Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy.”
Kenvue says it ‘strongly disagrees’ with Trump’s claims about acetaminophen
The FDA website says the agency has not found "clear evidence" that appropriate use of acetaminophen during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes."
Kenvue trims sales forecast, faces margin squeeze in 2025
The consumer health company, spun off from Johnson & Johnson in 2023, now expects net sales to decline in the low single digits.
Kenvue names Kirk Perry interim CEO
Perry replaces CEO Thibaut Mongon, who also resigned from the Kenvue board.
Video Forum: Pamela Gill Alabaster, Kenvue
Consumer health supplier forges plan of action for ESG